ANTX icon

AN2 Therapeutics
ANTX

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $134M invested in AN2 Therapeutics in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.3M
2
+$24.4M
3
+$20.6M
4
APM
Avidity Partners Management
Texas
+$10.4M
5
DM
Deerfield Management
New York
+$8.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$55.3M
2
$24.4M
3
$20.6M
4
$10.4M
5
$8.8M
6
$6.53M
7
$2.26M
8
$1.88M
9
$1.13M
10
$1.12M
11
$908K
12
$294K
13
$275K
14
$250K
15
$38K
16
$17K
17
$14K
18
$10K